Next Article in Journal
The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems
Next Article in Special Issue
QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles
Previous Article in Journal
-Omic Approaches and Treatment Response in Rheumatoid Arthritis
Previous Article in Special Issue
“Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(8), 1649; https://doi.org/10.3390/pharmaceutics14081649
Action Date Notes Link
article xml file uploaded 8 August 2022 11:11 CEST Original file -
article xml uploaded. 8 August 2022 11:11 CEST Update -
article pdf uploaded. 8 August 2022 11:11 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1649/pdf-vor
article supplementary file uploaded. 8 August 2022 11:11 CEST - https://www.mdpi.com/1999-4923/14/8/1649#supplementary
article html file updated 8 August 2022 11:13 CEST Original file -
article xml file uploaded 9 August 2022 09:35 CEST Update -
article xml uploaded. 9 August 2022 09:35 CEST Update https://www.mdpi.com/1999-4923/14/8/1649/xml
article pdf uploaded. 9 August 2022 09:35 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1649/pdf
article html file updated 9 August 2022 09:37 CEST Update -
article html file updated 13 August 2022 06:08 CEST Update https://www.mdpi.com/1999-4923/14/8/1649/html
Back to TopTop